Literature DB >> 16876125

First functional characterization of a singly expressed bacterial type II topoisomerase: the enzyme from Mycobacterium tuberculosis.

Alexandra Aubry1, L Mark Fisher, Vincent Jarlier, Emmanuelle Cambau.   

Abstract

Genome deciphering revealed that Mycobacterium tuberculosis encodes a single type II topoisomerase contrary to common bacteria harboring two type II topoisomerases (DNA gyrase and topoisomerase IV). Functions of the M. tuberculosis type II topoisomerase were explored after cloning and expressing the subunits encoding genes in Escherichia coli. M. tuberculosis type II topoisomerase supercoiled relaxed pBR322 with a specific activity close to that of DNA gyrases of common bacteria whereas it exhibited DNA relaxation and formation of cleavable complexes with activities significantly higher than other DNA gyrases. Intermolecular passage activity evaluated by the decatenation of kinetoplast DNA was 25-fold lower than that of the topoisomerase IV from Streptococcus pneumoniae, but was markedly higher than that of the E. coli gyrase. Overall, the type II topoisomerase of M. tuberculosis exhibits classical polyvalent activities of DNA gyrase for supercoiling but enhanced relaxation, cleavage, and decatenation activities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876125     DOI: 10.1016/j.bbrc.2006.07.017

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  42 in total

1.  Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance.

Authors:  Katie J Aldred; Sylvia A McPherson; Pengfei Wang; Robert J Kerns; David E Graves; Charles L Turnbough; Neil Osheroff
Journal:  Biochemistry       Date:  2011-12-16       Impact factor: 3.162

2.  Purification, crystallization and preliminary X-ray crystallographic studies of the Mycobacterium tuberculosis DNA gyrase CTD.

Authors:  Amélie Darmon; Jérémie Piton; Mélanie Roué; Stéphanie Petrella; Alexandra Aubry; Claudine Mayer
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-01-26

Review 3.  In front of and behind the replication fork: bacterial type IIA topoisomerases.

Authors:  Claudia Sissi; Manlio Palumbo
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

4.  Purification, crystallization and preliminary X-ray crystallographic studies of the Mycobacterium tuberculosis DNA gyrase ATPase domain.

Authors:  Mélanie Roué; Alka Agrawal; Craig Volker; Danuta Mossakowska; Claudine Mayer; Benjamin D Bax
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-05-25

5.  Purification, crystallization and preliminary X-ray diffraction experiments on the breakage-reunion domain of the DNA gyrase from Mycobacterium tuberculosis.

Authors:  Jérémie Piton; Stéphanie Matrat; Stéphanie Petrella; Vincent Jarlier; Alexandra Aubry; Claudine Mayer
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-10-30

6.  Optimization of pyrrolamides as mycobacterial GyrB ATPase inhibitors: structure-activity relationship and in vivo efficacy in a mouse model of tuberculosis.

Authors:  Shahul Hameed P; Suresh Solapure; Kakoli Mukherjee; Vrinda Nandi; David Waterson; Radha Shandil; Meenakshi Balganesh; Vasan K Sambandamurthy; Anand Kumar Raichurkar; Abhijeet Deshpande; Anirban Ghosh; Disha Awasthy; Gajanan Shanbhag; Gulebahar Sheikh; Helen McMiken; Jayashree Puttur; Jitendar Reddy; Jim Werngren; Jon Read; Mahesh Kumar; Manjunatha R; Murugan Chinnapattu; Prashanti Madhavapeddi; Praveena Manjrekar; Reetobrata Basu; Sheshagiri Gaonkar; Sreevalli Sharma; Sven Hoffner; Vaishali Humnabadkar; Venkita Subbulakshmi; Vijender Panduga
Journal:  Antimicrob Agents Chemother       Date:  2013-10-14       Impact factor: 5.191

7.  DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis.

Authors:  Alix Pantel; Stéphanie Petrella; Stéphanie Matrat; Florence Brossier; Sylvaine Bastian; Delphine Reitter; Vincent Jarlier; Claudine Mayer; Alexandra Aubry
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

8.  Fluoroquinolones stimulate the DNA cleavage activity of topoisomerase IV by promoting the binding of Mg(2+) to the second metal binding site.

Authors:  Lisa M Oppegard; Heidi A Schwanz; Tyrell R Towle; Robert J Kerns; Hiroshi Hiasa
Journal:  Biochim Biophys Acta       Date:  2015-12-23

9.  Mechanisms for defining supercoiling set point of DNA gyrase orthologs: I. A nonconserved acidic C-terminal tail modulates Escherichia coli gyrase activity.

Authors:  Elsa M Tretter; James M Berger
Journal:  J Biol Chem       Date:  2012-03-28       Impact factor: 5.157

10.  Twisting of the DNA-binding surface by a beta-strand-bearing proline modulates DNA gyrase activity.

Authors:  Tung-Ju Hsieh; Tien-Jui Yen; Te-Sheng Lin; Hsun-Tang Chang; Shu-Yun Huang; Chun-Hua Hsu; Lynn Farh; Nei-Li Chan
Journal:  Nucleic Acids Res       Date:  2010-03-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.